Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [21] Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
    Yoo, Joonsang
    Jeon, Jimin
    Baik, Minyoul
    Kim, Jinkwon
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [22] Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study
    Kim, Sun Hwa
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Jang, Hak Chul
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yong Soo
    Kim, Sang Jin
    Choi, Dong Seop
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (03) : E27 - E30
  • [23] Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes
    Dorkhan, M
    Lantz, M
    Frid, A
    Groop, L
    Hallengren, B
    CLINICAL ENDOCRINOLOGY, 2006, 65 (01) : 35 - 39
  • [24] Randomized Clinical Trial Assessing the Efficacy and Safety of Bromocriptine-QR when Added to Ongoing Thiazolidinedione Therapy in Patients with Type 2 Diabetes Mellitus
    Florez, Hermes
    Scranton, Richard
    Farwell, Wildon R.
    DeFronzo, Ralph A.
    Ezrokhi, Michael
    Gaziano, J. Michael
    Cincotta, Anthony H.
    JOURNAL OF DIABETES & METABOLISM, 2011, 2 (07)
  • [25] Clinical evidence of thiazolidinedione-induced improvement of pancreatic β-cell function in patients with type 2 diabetes mellitus
    Ovalle, F
    Bell, DSH
    DIABETES OBESITY & METABOLISM, 2002, 4 (01): : 56 - 59
  • [26] Safety and efficacy of exenatide over 16 weeks in patients with type 2 diabetes mellitus using a thiazolidinedione with or without metformin
    Zinman, B.
    Hoogwerf, B.
    Garcia, S. Duran
    Milton, D.
    Giaconia, J.
    Kim, D.
    Trautmann, M.
    Brodows, R.
    DIABETOLOGIA, 2006, 49 : 475 - 476
  • [27] Efficacy and safety of glimepiride (GLIM) in patients with type 2 diabetes uncontrolled on metformin (MET)/thiazolidinedione (TZD) combination therapy
    Roberts, VL
    Stewart, J
    Issa, M
    Lake, B
    Melis, R
    DIABETES, 2004, 53 : A144 - A144
  • [28] Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
    Habib, Zeina A.
    Havstad, Suzanne L.
    Wells, Karen
    Divine, George
    Pladevall, Manel
    Williams, L. Keoki
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 592 - 600
  • [29] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    DIABETES, 2010, 59 : A195 - A195
  • [30] Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes
    Buch, HN
    Baskar, V
    Barton, DM
    Kamalakannan, D
    Akarca, C
    Singh, BM
    DIABETIC MEDICINE, 2002, 19 (07) : 572 - 574
12345